FGFR1 and non-small cell lung carcinoma: In a comprehensive study across 675 cases of NSCLC, SqCC showed the highest frequency of FGFR1 amplification (~9%) compared to lung adenocarcinoma harbouring any FGFR abnormalities (~4%) [15].